Background: Standardized alcohol craving scales are rarely used outside of research environments despite recognized clinical utility. Scale length is a key barrier to more widespread application. A brief measure of alcohol craving is needed to improve research and treatment of alcohol use disorders (AUDs). Grounded in the Elaborated Intrusion Theory of Desire, the Alcohol Craving Experience (ACE) Questionnaire comprises two 11-item self-report scales that assess past-week frequency and maximum strength of alcohol craving. This study aimed to create a brief version of the ACE while maintaining psychometric integrity and clinical utility.
C
RAVING IS A robust marker of substance dependence severity and is implicated in treatment relapse (Flannery et al., 2003; Law et al., 2016; Yoshimura et al., 2016) . The DSM-5, recently included "craving, or a strong desire or urge to use a substance" as a diagnostic criterion for substance-use disorders (American Psychiatric Association, 2013) . Craving was defined as a strong desire to consume a substance that makes it difficult to think of anything else (American Psychiatric Association, 2013; Hasin et al., 2013) . Craving interventions feature prominently in psychological treatments, and pharmacotherapies have been developed to target craving neuromechanisms (Addolorato et al., 2005; Haass-Koffler et al., 2014) . After decades of experimental, clinical, and epidemiological research, accurate measurement of substance craving remains a research priority (Kavanagh et al., 2013; Tiffany and Wray, 2012) . Historically, craving has been measured by conceptually weak and often unstandardized methods, limiting generalizability and clinical utility (Kavanagh et al., 2013; Pavlick et al., 2009; Sayette et al., 2000) . Some standardized scales have been introduced, although uptake within clinical settings has been poor (Pavlick et al., 2009; Tiffany and Wray, 2012) .
A national survey of U.S. addiction services found that 99% considered craving in treatment planning, yet only 5% employed standardized self-report craving measures (Pavlick et al., 2009 ). The majority opted for single-item or nonstandard open-ended questions, despite well-documented limitations to the reliability of these approaches (Cortina, 1993; Hruschka et al., 2004) . This may reflect the psychometric and theoretical weaknesses in self-report craving scales (Kavanagh et al., 2013; Sayette et al., 2000) and time burden imposed by scale administration and interpretation in busy clinical environments. Alcohol use disorders (AUDs) are among the most prevalent substance-use disorders, placing a substantial burden upon global mortality and disease (Connor and Hall, 2015; Connor et al., 2016; Gowing et al., 2015) . A brief, psychometrically sound measure of alcohol craving is needed to improve assessment, diagnosis, and treatment of AUDs.
Measures vary considerably in their definition of craving. In a recent review of alcohol craving scales, based on 47 papers published between 1990 and 2012, we argued that the majority contain constructs conceptually and empirically distinct from diagnostic definitions of craving (e.g., DSM-5 and ICD-10; Kavanagh et al., 2013) . Allied constructs such as expectancies, intentions, and refusal self-efficacy were shown to be present within most craving measures (Kavanagh et al., 2013) . In a review of the clinical utility of drug craving, Tiffany and Wray (2012) argue that assessments of craving which include allied constructs are useful for research exploring the relationship between expressions of craving and craving-related phenomena. The inclusion of allied constructs may also enhance predictive validity of a scale, by drawing on the documented explanatory power of constructs such as intention to use and refusal self-efficacy (Connor et al., 2007) . However, scales assessing multiple constructs require careful interpretation to preserve construct validity. It is therefore important that craving measures are interpreted through a specified definition or theory. However, craving scales infrequently report a definition to which they adhere and are often atheoretical (Flannery et al., 1999; McHugh et al., 2016; Rojewski et al., 2015) . We developed the Alcohol Craving Experience (ACE) Questionnaire to be consistent with common definitions of craving while adhering to a specified theory (Statham et al., 2011) . As administration of the 22-item ACE can be too time-consuming for routine clinical use, a brief version is needed. It is proposed that reduction in the ACE would result in a theoretically and psychometrically sound measure of craving, which may be easily integrated in time-limited environments.
Reflecting the Elaborated Intrusion (EI) Theory of Desire (Kavanagh et al., 2005; May et al., 2014b) , the ACE measures 3 aspects of craving: the intensity of the drive to drink (Intensity), the presence of associated imagery (Imagery), and intrusiveness of desire cognitions (Intrusion; Statham et al., 2011) . EI theory defines craving as an affectively laden cognitive event, where an object or activity and its associated pleasure or relief is in focal attention (Kavanagh et al., 2005) . Consistent with neurobiological models of craving, addictive substances are believed to recruit the same physiological mechanisms that drive appetitive behaviors required for survival (Robinson and Berridge, 1993) . EI theory proposes that biological, environmental, and affective cues trigger intrusive desire-related cognitions which occupy attention and prompt elaboration. The subsequent elaboration process-in particular imagery-provides momentary pleasure or relief of physical and emotional discomfort (Connor et al., 2014) . However, pleasure or relief from elaborative cognitions quickly dissipates. Instead, awareness is drawn to any emotional or physical deprivation and to potential actions to acquire the target. Further elaboration and intensification of the desire ensues, unless the target is acquired or attention is captured elsewhere.
EI theory aligns with treatment approaches such as motivational enhancement, mindfulness, acceptance-based therapies, and retraining attentional biases (May et al., 2014b; Witkiewitz et al., 2013 Witkiewitz et al., , 2014 . Recent research has directly employed EI theory in the development of promising new craving management strategies and novel treatment approaches (Hsu et al., 2014; Tiggemann, 2007, 2013; Kn€ auper et al., 2011; Littel et al., 2016; Skorka-Brown et al., 2014) . These approaches employ nonsubstance imagery and sensory tasks designed to compete with cravingbased imagery within the limited capacity of working memory. The information provided by the ACE may facilitate more detailed formulation, treatment planning, and monitoring of craving.
The ACE was originally developed in an AUD sample (Statham et al., 2011) , to measure the frequency (ACE-F) and peak strength (ACE-S) of alcohol craving over the previous week. Exploratory and confirmatory factor analyses showed that the items in both forms of the ACE cluster into 3 distinct factors consistent with EI theory: Intensity, Imagery, and Intrusion of craving-related cognitions. The ACE has high internal reliability and significantly correlates with the Obsessive Compulsive Drinking Scale (OCDS), Alcohol Use Disorders Identification Test (AUDIT), as well as measures of psychological distress highly comorbid with AUDs. The ACE has further been demonstrated to discriminate nonclinical from clinical samples (Statham et al., 2011) . May and colleagues (2014a) pooled 12 studies using modified forms of the ACE to assess craving across a range of substances, including alcohol. The original factor structure was replicated across all substances.
The ACE provides a theoretically grounded, psychometrically robust measure, with strong rationale for more effectively targeting alcohol craving interventions. However, the full ACE is repetitive (with each item appearing in both the strength and frequency forms) and time-consuming, demanding time and effort of both respondent and administrator within busy clinical environments. A shorter version of the ACE is likely to result in higher uptake, especially where repeated administration is required. The aim of this study was to develop a short form of the ACE for use in treatment planning and outcome assessment without compromising its theoretical foundation or psychometric integrity.
MATERIALS AND METHODS

Participants
Three samples of data were drawn from patients attending a metropolitan university hospital alcohol and drug outpatient service. The service comprises 8 sessions of cognitive behavior therapy conducted over 12 weeks. Treatment may be supplemented by pharmacotherapy (naltrexone, acamprosate, or both). The assessment battery is completed in a separate consultation prior to the first treatment session and again at the completion of treatment. All patients were over 18 years of age and met DSM-IV-TR (American Psychiatric Association, 2000) criteria for alcohol dependence. Human ethics approval was obtained (2008/125, HREC/12/ QPAH/022 HREC/14/QPAH/664), and participants provided informed written consent. Sample characteristics are presented in Table 1 .
Scale Reduction Sample. This sample comprised 519 alcoholdependent patients (Table 1 ). These data have been used previously in the original development of the ACE (Statham et al., 2011) and in examining craving as a mediator of change (Law et al., 2016) , but have not been used to directly predict treatment outcome.
Validation Sample. The Validation Sample comprised pretreatment data from 228 consecutively treated alcohol-dependent patients (Table 1 ). These data were employed to assess the factor structure of the ACE scales and cross-sectional relationships between variables.
Test-Retest Sample. The ACE-F was administered to 66 patients at treatment sessions 1 and 2, in order to assess test-retest (TRT) reliability of the ACE-F. Mean time between sessions was 8.40 days (SD = 2.86).
Measures
The Alcohol Craving Experience Questionnaire. The ACE Questionnaire comprises two 11-item scales that assess the frequency (ACE-F) and peak strength (ACE-S) of desire-related cognitions over the previous week. Items load onto 3 classes of cognition, "Intensity" (items 1 to 3), "Imagery" (items 4 to 8), and "Intrusion" (items 9 to 11). Participants respond via an 11-point visual analogue scale with anchors 0 (not at all) and 10 (constantly/extremely). The ACE-F and ACE-S have good internal reliability and concurrent validity and can discriminate between problem and nonproblem drinkers (Statham et al., 2011) .
The Obsessive Compulsive Drinking Scale. The OCDS is a 14-item self-report measure intended to reflect drinking-related obsessive and compulsive craving and behavior (Anton et al., 1995) . The OCDS has received extensive research attention and is currently the most widely used measure of alcohol craving. The OCDS has acceptable TRT reliability, internal reliability, and concurrent validity (Anton et al., 1995; Kranzler et al., 1999; Roberts et al., 1999) . The OCDS cannot be considered a "pure" measure of craving as extraneous constructs such as consumption, effort to resist drinking, functional interference, and distress from drinking, as well as perceived control of drinking, are all assessed within the scale. The first 6 items comprising the Obsessions Subscale are most consistent with the clinical definitions of craving. OCDS-Obsessions is intended to assess drinking obsession-related cognitions, for example, "How much of your time when you're not drinking is occupied by ideas, thoughts, impulses, or images related to drinking?" While less confounded than the full OCDS, OCDS-Obsessions does contain extraneous phenomena, assessing functional interference and distress caused by obsessive cognitions. OCDS-Obsessions has been demonstrated to improve prediction of drinking behavior (Flannery et al., 2003) and likelihood of relapse posttreatment (Soyka et al., 2010) . As OCDS-Obsessions is a widely used measure of craving and considered among the better performing craving scales (Kavanagh et al., 2013) , it was employed as a concurrent measure of alcohol craving.
The Alcohol Use Disorders Identification Test. The AUDIT is a 10-item, self-report measure assessing recent alcohol use, symptoms of alcohol dependence, and alcohol-related problems (Saunders et al., 1993) . The AUDIT has sound internal reliability, sensitivity and specificity, and discriminant validity (Saunders et al., 1993) . Higher scores indicate increased risk of harmful or hazardous drinking.
The Beck Depression Inventory-Second Edition. The Beck Depression Inventory-Second Edition (BDI-II) is a 21-item selfreport measure assessing attitudes and behaviors symptomatic of depression (Beck et al., 1996) . The BDI-II is a well-validated measure demonstrating strong TRT and internal reliability, as well as good concurrent, content, discriminant, and construct validity (Beck et al., 1988 (Beck et al., , 1996 .
The State Anxiety Scale (S-Anxiety). The S-Anxiety of the State Trait Anxiety Inventory comprises 20 self-report items assessing the respondent's current state of anxiety (Spielberger, 1983) . The S-Anxiety has acceptable internal and TRT reliability, as well as content, discriminant, and construct validity (Barnes et al., 2002; Oei et al., 1990; Spielberger, 1983) .
Procedure
Scale Reduction. To best maintain consistency of the measured construct, an initial step involved selection of a form of the ACE for further refinement (ACE-F or ACE-S). Each form was evaluated The Scale Reduction Sample records medication (naltrexone/acamprosate/both) if it is prescribed at any point during treatment. Medication is only counted in the Validation and TRT samples if it was taken in the week prior to assessment. As the Validation sample assessment occurred prior to commencement of behavioral treatment and TRT sample was assessed in session 1, the majority of patients had not yet been prescribed pharmacotherapy.
based on perceived clinical utility and predictive validity. Decisions guiding subsequent item reduction were informed by the following rationale: (i) to enhance construct validity, items with the greatest face validity and theoretical importance within EI theory were prioritized; (ii) to maximize the sensitivity and clinical utility of a reduced scale, the most highly endorsed items were also prioritized for retention; and (iii) to enhance predictive validity, the capacity of items to discriminate between patients who lapsed or withdrew from treatment and those who were abstinent throughout treatment was also considered. Data analyses within this step utilized the Scale Reduction Sample.
Scale Evaluation. Reduced models were further evaluated based on construct, predictive, concurrent, and convergent validity, as well as internal and TRT reliability. Predictive validity of OCDSObsessions was also assessed for concurrent comparison. Data analysis within this step utilized the Validation and TRT samples.
Scale Selection. The shortest scale maintaining psychometric integrity would be selected as the final reduced version.
Data Analysis
Analyses were conducted in SPSS version 22 (IBM, Armonk, NY). Confirmatory factor analyses (CFAs) were conducted in R version 3.2.1 (R Core Team, 2015), package extension lavaan .5 to 18 (Rosseel, 2012) . As the distributions of all ACE item and scale scores were significantly negatively skewed, statistical procedures robust to nonnormal distributions were utilized. CFA models were compared using changes in v 2 /df ratios (smaller values indicating improved fit; Carmines and McIver, 1981) , comparative fit indices (CFIs; values >0.93 indicating good fit; Hu and Bentler, 1999) , standardized root-mean-square residual (SRMR; values <0.07 indicating good fit; Hu and Bentler, 1999) , root-mean-square error of approximation (RMSEA; values <0.07 indicating good fit; Hu and Bentler, 1999) , and Akaike information criterion (AIC; smaller values indicating improved fit; Bozdogan, 1987) .
RESULTS
Scale Reduction
Subscale Selection. As the ACE-S asks the respondent to report on only the most severe episode of past-week craving, it is influenced by contextual factors such as situational cues and novel stressors. Clinical value of this method is drawn from the isolation of a specific time period where the patient may be most vulnerable to lapse. Alternatively, the ACE-F assesses the perceived frequency of craving symptoms over the past week, providing a more general overview of the patients' craving experience. The ACE-F was subsequently identified as the preferred scale for reduction, based on its perceived benefit as a measure more sensitive to change in the patient's typical craving experience.
Using the Scale Reduction Sample, separate logistic regression analyses were employed to assess the capacity of pretreatment ACE scale scores to predict the likelihood of treatment lapse relative to patients who were abstinent throughout treatment. Patients who discontinued treatment without record of lapse were conservatively included within the lapse group. All scale scores were standardized to facilitate the comparison of effects. AUDIT scores and medication status were included as covariates, but did not significantly improve upon the intercepts-only model, v 2 (2) = 0.26, p = 0.877, Nagelkerke R 2 = 0.001; (1) = 21.68, Dp = <0.001, Nagelkerke DR 2 = 0.062, Table 2 , Model 2, significantly improved the predictive power of the model. As Model 2 appeared to explain more variance than Model 1, the ACE-F was added to Model 1 in an additional step to examine whether it would account for significantly more variance than the ACE-S. The addition of the ACE-F to Model 1 saw that the ACE-F become the dominant predictor within the model, although predictive power was not significantly improved, Dv 2 (1) = 3.63, Dp = 0.057, Nagelkerke DR 2 = 0.011, Table 2 , Model 3. The ACE-F was subsequently selected for further refinement.
Item Importance. Prior to item reduction, the structure and items central to the theoretical foundation of the scale were considered. At least 1 item from each subscale was retained to represent each factor. Items 3 and 9 (Table 3) were prioritized for retention due to high semantic consistency to the Intensity and Intrusion factors, respectively. Multiple items of the Imagery factor would be retained to capture potential individual differences in the most prevalent imagery modalities involved in alcohol craving.
Feature Prevalence. Medians and interquartile ranges for all ACE-F items are presented in Table S1 within the online Supplementary material. While all items had an interquartile range of at least 4 on the 11-point scale, most also received a large proportion of "not at all" responses. To identify which items were most representative of common craving symptoms among patients with AUD, the endorsement rates (ERs; proportion of nonzero responses to each item) were also calculated. McNemar's v 2 was utilized to identify significant differences between items in the prevalence of ERs within each factor. Within the Intensity factor, the ER of item 2 (80.2%) was significantly lower than that of item 3 (86.1%, p < 0.001), while items 1 (87.6%) and 3 could not be distinguished (p = 0.169). Comparisons of ERs of items within the Imagery factor revealed all were significantly different (p < 0.001), with the exception of the most highly endorsed, items 4 (80.9%) and 8 (80.1%, p = 0.716). Within the Intrusion factor, item 11 was the least endorsed factor (75.8%, p < 0.001), while items 9 (84.9%) and 10 (83.8%) could not be differentiated (p = 0.291).
Separate Mann-Whitney U-tests revealed that the mean rank of patients who lapsed or withdrew from treatment was significantly higher for every item than those who completed treatment abstinent (Table 3 ). Steiger's Z revealed no significant differences in the size of the effects between items.
Item Reduction. To maximize sensitivity of the reduced craving measure, items with the highest ERs were given greater priority for retention to minimize the number of "not at all" responses within the reduced scale. Based on feature prevalence and consistency with the overarching factors, items 3 and 9 were retained to represent the Intensity and Intrusion factors, respectively. The 3 imagery items with the highest ERs (4, 5, and 8) were retained to comprise the initial Imagery factor.
A sequential logistic regression analysis was employed to assess the capacity for the selected items to predict alcohol lapse in the Scale Reduction Sample. Addition of the items intended to comprise the reduced ACE (items 3, 4, 5, 8, 9) to the Baseline Model (Table S2 ) significantly improved predictive power of the model, Dv 2 (5) = 21.49, Dp < 0.001, Nagelkerke DR 2 = 0.061, Model 4, Table S2 . To assess whether the model could be improved with the inclusion of additional ACE items, the remaining items were included using forward entry. Sequential inclusion of items 1, Dv 2 (1) = 7.61, Dp = 0.006, Nagelkerke DR 2 = 0.023, Model 5, Table S2 , and 10, Dv 2 (1) = 9.84, Dp = 0.002, Nagelkerke DR 2 = 0.027, Model 6, Table S2 , would significantly improve the final model, v 2 (9) = 39.20, p < 0.001, Nagelkerke R 2 = 0.111.
Scale Evaluation
Validity. To assess the construct validity of the initial 5-item scale, the 7-item scale, and the complete ACE-F, confirmatory factor analyses were performed utilizing the Validation Sample. Maximum-likelihood estimation with robust standard errors and a Satorra-Bentler-scaled test statistic were employed to reduce the effects of nonnormality. Model fit statistics are presented in Table 4 , and parameter estimates are summarized in the Supplementary material. For the 11-and 7-item scales, the 3-factor solution provided a better fit to the data than a unifactorial model (Table 4) . For the 5-item scale, both solutions showed comparable fit. The CFI, RMSEA, SRMR, and AIC fit statistics all improved through reduction. No covariance between error terms was specified in any of the models. These results support previous studies validating the 3-factor structure of the ACE (May et al., 2014a; Statham et al., 2011) , although when reduced to a 5-item scale, it could equally reflect a global construct of craving within a single factor (Fig. 1) .
Data from the Validation Sample indicated that all scales had significant (p < 0.001) large positive correlations with OCDS-Obsessions, indicating an acceptable level of concurrent validity (r = 0.60 to 0.58). Convergent validity was demonstrated by significantly (p < 0.01) small-to-moderate positive correlations with the AUDIT (r = 0.22 to 0.20) and significantly (p < 0.001) moderate correlations with measures of anxiety (S-Anxiety: r = 0.40 to 0.38) and depression (BDI-II: r = 0.39 to 0.38). The strength of the correlations did not significantly differ between the 3 ACE versions (Steiger's Z, p < 0.05), indicating that convergent and concurrent validity of the ACE was not significantly affected by scale reduction. Utilizing the Scale Reduction Sample predictive validity of the scales administered pretreatment was assessed by logistic regression analysis with the outcomes "complete treatment abstinent" and "lapsed or discontinued treatment." When independently added to the Baseline Model, the 5-item, Dv 2 (1) = 15.17, Dp < 0.001, Nagelkerke DR 2 = 0.044, Model 7, Table 5 , 7-item, Dv 2 (1) = 20.19, Dp < 0.001, Nagelkerke DR 2 = 0.058, Model 8, Table 5 , and 11-item (Model 2, Table 2 ) scales all significantly improved predictive power of the model. Predictive power of OCDS-Obsessions was also assessed for concurrent comparison. Addition of OCDSObsessions significantly improved upon the Baseline Model, Dv 2 (1) = 7.78, Dp = 0.005, Nagelkerke DR 2 = 0.022, Model 9, Table 5 . The incremental validity of each scale was assessed by systematically adding the weaker of 2 scales, based on Nagelkerke R 2 , to the Baseline Model, followed by the next strongest scale in step 2. The 5-item ACE-F was demonstrated to significantly improve upon the predictive power of OCDS-Obsessions, Dv 2 (1) = 7.35, Dp = 0.007, Nagelkerke DR 2 = 0.044, Model 10, Table 5 , and the 7-item scale significantly improved upon the 5-item, Dv
2
(1) = 15.43, Dp < 0.001, Nagelkerke DR 2 = 0.088, Model 11, Table 5 . The 11-item scale did not improve upon the 7-item scale, Dv 2 (1) = 1.19, Dp = 0.173, Nagelkerke DR 2 = 0.064, Model 12, Table 5 .
Reliability. Internal consistency was assessed using the Validation Sample. Cronbach's alpha was above 0.90 for all scales with only minor reductions in the reduced scales (a = 0.95 to 0.92). TRT reliability utilized session 1 and 2 data from 66 patients. Correlations between session 1 and 2 ACE scores indicated that TRT reliability was acceptable across all scales (r = 0.731 to 0.725). Steiger's Z revealed no significant changes in scale TRT reliability following reduction.
Scale Selection
The procedures conducted indicate that the ACE-F may be reduced to as few as 5 items while maintaining theoretical and psychometric integrity. The 5-item scale, termed the Mini Alcohol Craving Experience (MACE), was chosen as the most suitable short-form scale for assessment of craving in AUD populations.
DISCUSSION
In place of the two 11-item forms of the ACE, a brief 5-item measure of craving was validated (MACE). The MACE maintained high construct, predictive, concurrent, and convergent validity. High internal and TRT reliability consistent with the ACE-F was also demonstrated. The MACE measures the frequency of past-week craving including intense urges, imagery, and intrusiveness of craving-related cognitions (Kavanagh et al., 2005) . The MACE is simple to administer and may be completed in less than 60 seconds, reducing time burden on respondents, health professionals, and researchers. In addition to its brevity, the MACE maintains several strengths uncommon among current craving instruments, including a strong theoretical model and absence of drinking constructs known to confound craving measurement (Kavanagh et al., 2013; Sayette et al., 2000) . By retaining the items most representative of the ACE factors, and monitoring the resultant model fit, the MACE preserved the construct validity of the ACE. The MACE subsequently retains the capacity for unique insight into intensity and intrusiveness of patient craving, as well and key elements of craving-based imagery. This information may inform case formulation and treatment planning.
Predictive validity is infrequently examined in existing craving measures. Higher scores on the MACE were predictive of increased risk of lapse or dropout from treatment in this alcohol-dependent sample. A 1 standard deviation increase in MACE score was associated with a 54% increase in the odds of lapse or discontinuation of treatment, relative to OCDS-Obsessions, where a 1 standard deviation score increase was associated with a 10% increase in risk. The practical interpretation of this result is that for every 1-point increase on the MACE pretreatment (maximum score = 50), the odds of a patient completing treatment abstinent reduced by 3.1%. The MACE may therefore assist addiction professionals to better assess risk of relapse in their patients.
Few craving measures assess TRT reliability. The MACE deliberately measures past-week frequency of craving, under the assumption that this will have greater stability and subsequently be a more reliable indicator of change than single time point assessments. The correlation of session 1 and 2 MACE scores was r = 0.73 and is interpreted as an acceptable degree of stability within the clinical context. Given the prominence of craving within clinical and research settings, a measure of craving sensitive to change over time is greatly needed. The MACE may enhance the validity of studies assessing the efficacy of craving interventions, and improve monitoring of patients' treatment response in clinical settings.
As this study was conducted in a hospital outpatient clinic, the samples provided optimal, clinically relevant data. However, the practical nature of the research design introduced some limitations. The samples predominantly comprised middle-aged men with poor social or occupational functioning and moderate-to-severe alcohol dependence. Future studies should investigate the MACE in more diverse patient populations, as craving profiles may vary across problem severity, age, culture, social-occupational status. An additional limitation is that follow-up data of patients who dropped out were not available and were conservatively recorded as having lapsed. Assessment of TRT reliability was also impaired by the treatment setting. An increased focus on drinking and attempts to change drinking behaviors is likely to have increased variance in patient craving from session 1 to 2. While this is hypothesized to have led to the underestimation of the MACE's stability, future research should assess participants under stable conditions with tightly controlled time points. Further research is also needed to examine the performance of the MACE as a stand-alone measure. As the MACE was only assessed as a subselection of the full ACE, the extent to which the variance of the retained items is influenced by the excluded items is unknown. Finally, while craving frequency presents ongoing challenges to the control of drinking, very intense peak levels also constitute significant risk. Utilizing both frequency and strength forms of the ACE is recommended when time permits, as they offer a more comprehensive assessment of the patient's experience of craving. The MACE and ACE scales, scoring instructions, and normative data are included in the online Supplementary material.
A final recommendation, which applies to the use of all craving measures, is that scores are carefully interpreted in light of the definition and theory under which they are proposed. It is argued that unclear definitions and the absence of theoretical models have impaired craving measurement to date, confounding the craving construct (Kavanagh et al., 2013; Tiffany and Wray, 2012) . Interpreting ACE scores in the context of the EI Theory of Desire (Kavanagh et al., 2005) will improve understanding of the proposed construct of craving and enhance the measure's clinical utility. The MACE reflects the key theoretical elements of the ACE while maintaining the best performing items and preserving psychometric integrity. Key strengths of the MACE include excellent construct validity, predictive validity, and acceptable TRT reliability. In conjunction with its brevity, these features make the MACE ideal for use with AUD populations in time-limited clinical and research environments.
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